NEW YORK (GenomeWeb) – PerkinElmer reported after the close of the market on Monday that its third quarter revenues fell 3 percent, with Chairman and CEO Robert Friel blaming "challenging market conditions" for the drop.

For the three months ended Oct. 2, the company said revenues fell to $548.1 million from $563.4 million in Q3 2015, widely missing Wall Street analysts' average estimate of $572.0 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.